Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Alzheimers Disease Update"

04:03 EDT 18th April 2014 | BioPortfolio

Matching Channels

Vascular Dementia

Vascular Dementia accounts for 25% of all dementias (the second most commen cause after Alzheimers. It is the cumulative effects of many small strokes - patients often have evidence of vascular path...

Huntington's Disease

Huntington's disease is a hereditary disease caused by a defect in a single gene on Chromosome 4 that is inherited in an autosomal dominant fashion. The defect causes a part of DNA, called a CAG...

Eye disease

Gaucher's disease

Gaucher's (go-SHAYZ) disease occurs when certain harmful fatty substances accumulate to excessive levels in your liver, spleen, lungs, bone marrow and, less commonly, brain. This accumulation of...

Hemoglobin SC Disease

Matching News

Ebola virus disease, West Africa – update

In this update and subsequent ones, the terminology Ebola haemorrhagic fever will be replaced by Ebola virus disease (EVD) in line with the International Classification of Diseases (ICD-10). Therefore...

What's It Like to Care for Someone Close to You With Alzheimers?

What's It Like to Care for Someone Close to You With Alzheimers?

U.S. health continues to be threatened by heart disease and stroke

Heart disease and stroke remain two of the top killers of Americans and pose a significant threat to millions of others, according to the American Heart Association's Heart Disease and Stroke Statisti...

Links for you…

$230 million for Alzheimers research. 100 books. Uber for health care? Thoughts on paying for kidneys. The end of nursing shortages?

Prana Biotechnology provides update on IMAGINE PBT2 trial for Alzheimer’s disease

Prana Biotechnology, a developer of best-in-class treatments for neurodegenerative disease, today provided an update of its IMAGINE Alzheimer’s Disease Extension trial.

Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial / 83% of Patients Completing Treatment in IMAGINE Trial Opt to Join Extension

MELBOURNE, AUSTRALIA -- (Marketwired) -- 12/10/13 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT), a developer of best-in-class treatments for neurodegenerative disease, today provided an update o...

The Number of Suspected and Confirmed Cases of Ebola Climbs to 122

(Note: In this update and subsequent ones, the terminology Ebola hemorrhagic fever will be replaced by Ebola virus disease (EVD) in line with the International Classification of Diseases (ICD-10). The...

UPDATE 1-Study casts doubt on whether extra vitamin D prevents disease

* Vit D supplements may not help ward off chronic disease

Matching PubMed Articles

Update on the surgical management of Paget's disease.

Mammary Paget's disease is a rare form of breast neoplasm that often presents with a pruritic eczema-like rash involving the nipple-areolar complex, and is refractory to common remedies. It is often a...

Self management for patients with chronic obstructive pulmonary disease.

Self management interventions help patients with chronic obstructive pulmonary disease (COPD) acquire and practise the skills they need to carry out disease-specific medical regimens, guide changes in...

Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?

Aging is the common denominator and the highest risk factor for macular degeneration and Alzheimers Disease (AD). Important pathological hallmarks common to both diseases are the presence of amyloid ...

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.

To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARD) in patients with rheumatoid arthritis (RA) to inform the European League Against Rheumatism(EULAR)...

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

To update a previous systematic review assessing the efficacy of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis (RA).

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement